| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |